Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001596770-16-000104
Filing Date
2016-02-12
Accepted
2016-02-12 17:17:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 ATYR PHARMA SCHEDULE 13G 2-12-2016 schedule13g.htm SC 13G 174257
  Complete submission text file 0001596770-16-000104.txt   175734
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Subject) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE
Type: SC 13G | Act: 34 | File No.: 005-88839 | Film No.: 161420748
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111 415-362-4022
Alta Partners VIII, L.P. (Filed by) CIK: 0001399763 (see all company filings)

EIN.: 204774702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G